Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.

Clinical trial NCT00423254 · COMPLETED

Trial details

NCT number: NCT00423254
Sponsor: Mannkind Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Ovarian Melanoma Renal Prostate Colorectal Endometrial Carcinoma Cervical Carcinoma Testicular Cancer Thyroid Cancer Small Cell Lung Carcinoma Mesothelioma Breast Carcinoma

Start date: 2007-02-01
Primary completion: 2009-09-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.